Prestige Brands Holdings, Inc. to Release Fiscal 2017 Second Quarter Earnings on November 3rd

TARRYTOWN, N.Y.--(BUSINESS WIRE)--

Prestige Brands Holdings, Inc. PBH today announced that it will issue its fiscal 2017 second quarter earnings release on Thursday, November 3, 2016 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To access the call, listeners calling from within North America may dial 844-233-9440 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 574-990-1016. The conference ID is 94506453. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrands.com.

Telephonic replays will be available for two weeks following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406 from outside North America. The conference ID is 94506453.

About Prestige Brands Holdings, Inc.

Prestige Brands markets and distributes brand name over-the-counter healthcare and household cleaning products throughout the U.S. and Canada, Australia, and in certain other international markets. Core brands include Monistat® women's health products, Nix® lice treatments, Chloraseptic® sore throat treatments, Compound W® wart treatments, Clear Eyes® eye care products, DenTek® oral care products, Little Remedies® pediatric products, The Doctor's® NightGuard® dental protector, Efferdent® denture care products, Luden's® throat drops, Dramamine® motion sickness treatments, BC® and Goody's® headache remedies, Beano® gas prevention, Debrox® earwax remover, and in Canada, Gaviscon® antacid.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006015/en/